Table 1.
Quartiles of plasma phospholipid oleic acidb | ||||
---|---|---|---|---|
Q1 (low) 8.1 [6.2–8.7] | Q2 9.1 [8.7–9.4] | Q3 9.8 [9.4–10.1] | Q4 (high) 10.9 [10.1–16.0] | |
Characteristics | (N= 388) | (N= 408) | (N= 386) | (N= 394) |
Age (y) | 58.0 ± 7.8 | 58.9 ± 7.8 | 58.7 ± 8.1 | 59.2 ± 8.4 |
Body mass index (kg/m2) | 25.4 ± 2.9 | 25.2 ± 2.9 | 25.2 ± 3.0 | 24.9 ± 2.8 |
Ratio of MUFA:SFAc | 0.20 ±0.01 | 0.22 ±0.01 | 0.24 ± 0.01 | 0.27 ± 0.02 |
Plasma palmitoleic acidc | 0.28 ±0.09 | 0.31 ±0.10 | 0.32 ± 0.13 | 0.39 ± 0.21 |
Plasma 18:0c | 14.3 ± 1.3 | 13.9 ± 1.2 | 13.9 ± 1.1 | 13.5 ± 1.2 |
Plasma marine n-3c | 5.3 ±1.43 | 4.8 ± 1.4 | 4.5 ± 1.1 | 4.0 ± 1.0 |
Prevalent diabetes (%) | 6.4 | 4.4 | 4.4 | 7.1 |
Prevalent CHD (%)d | 16.5 | 15.4 | 16.3 | 12.7 |
Hyperlipidemia (%) | 17.9 | 18.4 | 12.1 | 11.4 |
Hypertension (%) | 34 | 29.8 | 29.8 | 31 |
Atrial Fibrillation | 4.1 | 2.9 | 3.6 | 5.1 |
Current smoking (%) | 6.4 | 10.8 | 11.4 | 16.2 |
Never smokers (%) | 45.4 | 48.2 | 45.5 | 41.6 |
Current alcohol intake (%) | 84.7 | 85.2 | 84.2 | 81.9 |
Vigorous exercise (%) | 70.4 | 73.6 | 72.9 | 77.6 |
Aspirin use | 53.6 | 48.28 | 45.1 | 50.1 |
Follow-up time (years) | 17.4 ±6.0 | 16.7 ±6.0 | 17.5 ±5.6 | 16.5 ±6.6 |
Age at HF Event (years) | 75.1 ±8.2 | 76.1 ±9.2 | 75.9 ±8.3 | 76.0 ±8.4 |
Data are presented as medians (minimum-maximum), means ± standard deviation, or %. Few participants had missing data on hypertension (n = 10), smoking (n = 2), alcohol use (n = 6), and physical activity (n = 10).
Quartiles of oleic acid presented as percent of total fatty acids.
Plasma phospholipid fatty acids expressed as percentage of total plasma phospholipids (SFA: saturated fatty acids). Palmitoleic acid, 16:1.
CHD: coronary heart disease (myocardial infarction, coronary angioplasty or bypass surgery).